A substantial portion of litigation concerning baby formula in the United States has been concentrated within two Illinois counties. According to reports, approximately 90 percent of these cases are being funneled into these specific jurisdictions. This geographic clustering has drawn scrutiny from legal analysts and industry observers who question the motivations behind such a high concentration of filings.

Critics of this legal trend, including those cited by The Hill, suggest that the strategy is less about the strength of the scientific evidence and more about the selection of a favorable venue. The argument presented is that plaintiffs' attorneys are utilizing a specific business model designed to secure outcomes in courtrooms perceived as more receptive to their claims, regardless of the underlying scientific consensus. This perspective characterizes the litigation as a strategic effort to bypass the limitations of the evidence by choosing a jurisdiction that may be more likely to deliver favorable results for the plaintiffs.

While the report highlights the concentration of these cases, it does not provide a detailed rebuttal from the plaintiffs' legal teams regarding their choice of venue. The focus remains on the assertion that the legal strategy is the primary driver of the litigation's success, rather than the merits of the health claims themselves. As these cases continue to move through the Illinois court system, the debate over venue shopping and the role of scientific evidence in mass tort litigation remains a central point of contention.